| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |